Wolverine Trading, LLC Nymox Pharmaceutical Corp Put Options Transaction History

Wolverine Trading, LLC

7 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2020 Aug 13, 2020	BUY	$2.1 - $4.6 $8,820 - $19,320	4,200 Added 36.84%	15,600 $55,000
Q1 2020 May 11, 2020	SELL	$1.69 - $3.88 $29,068 - $66,736	-17,200 Reduced 60.14%	11,400 $25,000
Q4 2018 Feb 14, 2019	SELL	$1.31 - $2.53 $49,256 - $95,127	-37,600 Reduced 56.8%	28,600 $41,000
Q3 2018 Nov 14, 2018	SELL	$2.46 - $3.7 $84,624 - $127,280	-34,400 Reduced 34.19%	66,200 $163,000
Q1 2018 May 15, 2018	BUY	$3.09 - $4.43 $130,089 - $186,503	42,100 Added 71.97%	100,600 $426,000
Q4 2017 Feb 14, 2018	SELL	$3.29 - $4.06 $24,675 - $30,449	-7,500 Reduced 11.36%	58,500 $193,000
Q3 2017 Nov 15, 2017	BUY	$3.36 - $4.02 $221,760 - $265,320	66,000	66,000 $252,000

150K

Ticker NYMX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 91,265,000
Market Cap $42.9M
Description
Nymox Pharmaceutical Corporation, a biopharmaceutical company, engages in the research and development of drugs for the aging population in Canada, the United States, Europe, and internationally. Its lead drug candidate is Fexapotide Triflutate (NX-1207), which has completed Phase III clinical trials for the treatment of benign prostatic hyperpl...

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Trading, LLC with notifications on news.